an approval in Part 2 and the submission of the registration statement and draft prospectus in Part 4; (b) the CLMV company shall comply with the rules related to an approval in Part 3 and the
less than three-fourths of the votes of the shareholders attending such meeting and having the right to vote. In addition to seeking approval for the allocation and offering of the Company’s newly issued
Businesses/Assets come with 269 patents with further 191 patents pending approval. In addition, the Transaction shall be a combination of business and asset purchase. In case of equity purchase, there will be
were part of a certain number of assets to be disposed, which received shareholders’ approval at the EGM held on 4 January 2018 MANAGEMENT DISCUSSION & ANALYSIS 2018 14 FEB 2019 U CITY PCL 2018 MD&A (for
the satisfaction (or jointly waiver by the Seller and the Company) of all the following conditions precedent: (a) The Company is granted approval by its shareholders meeting to acquire the shares of
the satisfaction (or jointly waiver by the Seller and the Company) of all the following conditions precedent: (a) The Company is granted approval by its shareholders meeting to acquire the shares of
the satisfaction (or joint waiver by the Seller and the Company) of all the following conditions precedent: (a) The Company is granted approval by its shareholders meeting to acquire the shares of GLOW
statement of the Company ended March 31, 2019. After the computation of the transaction size together with the Company’s other acquisition transactions within the past 6 months prior to the approval of the
Extraordinary General Meeting of Shareholders No. 1/2017 for approval of criteria for directors and executives’ remuneration for the year 2017 in the form of bonuses. The details are as follows; 1) Annual
Extraordinary General Meeting of Shareholders No. 1/2017 for approval of criteria for directors and executives’ remuneration for the year 2017 in the form of bonuses. The details are as follows; 3 1) Annual